These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38995716)

  • 1. Assessment of the impact of cytomegalovirus seropositivity on blood parameters in renal hemodialysis patients.
    Emad R; Badr-Aldin WY; Anani M; Marei YE; Sakr MG; Ibrahim GA
    Egypt J Immunol; 2024 Jul; 31(3):113-122. PubMed ID: 38995716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.
    Sepehrvand N; Khameneh ZR; Eslamloo HR
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):363-7. PubMed ID: 20228534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
    Fowotade A; Okonko IO; Agbede OO; Suleiman ST
    Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of cytomegalovirus infections in Croatia.
    Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD.
    Betjes MG; Weimar W; Litjens NH
    J Am Soc Nephrol; 2009 Dec; 20(12):2661-6. PubMed ID: 19820127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cytomegalovirus infection among patients undergoing hemodialysis.
    Abou-El-Yazed E; El-Hoseny IM; Kasim K; El-Sadek AA; Morsy ; Amar A
    Egypt J Immunol; 2008; 15(2):33-41. PubMed ID: 20306686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease.
    Karangizi AHK; Chanouzas D; Fenton A; Moss P; Cockwell P; Ferro CJ; Harper L
    QJM; 2020 Apr; 113(4):253-257. PubMed ID: 31613364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
    Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
    East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of CMV IgG and IgM in Korean women of childbearing age.
    Choi R; Lee S; Lee SG; Lee EH
    J Clin Lab Anal; 2021 Apr; 35(4):e23716. PubMed ID: 33783845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological markers as indicators for congenital cytomegalovirus infection.
    Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
    Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
    Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
    Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of cytomegalovirus (CMV) IgG and IgM in homosexuals and transsexuals using ELISA].
    Kiyan M; Cengiz AT; Kendi O; Tümer AR; Bilge Y; Uğurel MS
    Mikrobiyol Bul; 1993 Apr; 27(2):119-26. PubMed ID: 8388984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
    Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
    BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey.
    Uyar Y; Balci A; Akcali A; Cabar C
    New Microbiol; 2008 Oct; 31(4):451-5. PubMed ID: 19123299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival.
    Fitzgerald JT; Gallay B; Taranto SE; McVicar JP; Troppmann C; Chen X; McIntosh MJ; Perez RV
    Transplantation; 2004 May; 77(9):1405-11. PubMed ID: 15167599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Cytomegalovirus antibodies and primary infection among hemodialysis patients: A systematic and meta-analysis review.
    Mesgar Saravi N; Mousavi T
    Transpl Immunol; 2022 Jun; 72():101587. PubMed ID: 35339658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.
    Aljumaili ZK; Alsamarai AM; Najem WS
    J Infect Public Health; 2014; 7(4):277-88. PubMed ID: 24629348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of cytomegalovirus infection among children between the ages of 4 and 12 years in Taiwan.
    Shen CY; Chang WW; Chang SF; Chao MF; Huang ES; Wu CW
    J Med Virol; 1992 May; 37(1):72-5. PubMed ID: 1320100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.